FIELD: chemistry.
SUBSTANCE: invention relates to a method of modulating expression of a target gene induced by β-catenin using an agent which increases linkage of p300 with β-catenin and reduces linkage of CBP with β-catenin, involving bringing a composition containing β-catenin, CBP and p300, where β-catenin is more likely linked to CBP than p300, into contact with an agent in an amount which is effective for changing the probability of linking β-catenin to CBP compared to p300, where the said agent is a compound with a structure selected from formula (I), or its stereoisomers: where A represents -(C=O)-, B represents -(CHR4)-, D represents -(C=O)-, E represents -(ZR6)-, G represents -(XR7)n-> W represents (C=O)NH-, X represents nitrogen or CH, Z represents CH, n = 0 or 1. Values of substitutes R1 and R2 are indicated in the formula of invention. The invention also relates to a composition for modulating expression of a target gene induced by β-catenin.
EFFECT: novel compounds have useful biological properties.
9 cl, 7 tbl, 30 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
MIMETICS WITH REVERSE CONFIGURATIONS AND METHODS OF THEIR ADMINISTRATION | 2004 |
|
RU2342387C2 |
AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
WNT ANTAGONISTS AND METHODS OF TREATING AND TESTING | 2011 |
|
RU2593947C2 |
SELECTION OF CANCER PATIENTS FOR INTRODUCTION OF WNT SIGNAL INHIBITORS BASED ON RNF43 MUTATION STATUS | 2013 |
|
RU2636000C2 |
METHOD OF INDUCTION OF PLURIPOTENT STEM CELLS DIFFERENTIATION INTO CARDIOMYOCYTES | 2007 |
|
RU2433174C2 |
GENE DELIVERY, MEDIATED BY NANOPARTICLES, GENE CORRECTION AND LIGAND-DIRECTED MODIFICATION IN VARIOUS CELL POPULATIONS | 2014 |
|
RU2670512C2 |
MONOCLONAL ANTIBODY AGAINST FZD10, ITS USE | 2017 |
|
RU2765431C2 |
ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
LENTIVIRAL REPORTER VECTOR SYSTEM FOR MEASURING ACTIVITY OF KEY TRANSCRIPTIONAL FACTORS REFLECTING FUNCTIONAL STATUS OF SIGNALLING PATHWAYS OF CELL | 2009 |
|
RU2420584C1 |
DOSING REGIMEN OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN A COMBINATION | 2018 |
|
RU2767533C2 |
Authors
Dates
2010-03-10—Published
2004-08-27—Filed